Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies

Chair: Meena Bansal (USA)

18:45 – 18:55	Introduction. The Growing Burden of MASLD/MASH: A Call to Action	Meena Bansal (USA)
18:55 – 19:10	THR-β Agonists and Other Disease-specific Therapies Poised to Change the Paradigm	Juan Pericàs (ESP)
19:10 – 19:20	Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy	Michael Roden (DEU)
19:20 – 19:40	Clinical Case Challenge: Integrating MASLD/MASH-Specific Therapy into Practice	Meena Bansal (USA)
19:40 – 19:45	Q&A	All faculty

This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

This activity is supported by an educational grant from Madrigal Pharmaceuticals.

INDUSTRY